Showing results (331-340 of 531) with videos related to

Sort By:
Pageof 54
The American Journal of Cardiology|July 22, 1998
Platelet glycoprotein IIb/IIIa receptor blockade with abciximab reduces ischemic complications in patients undergoing directional coronary atherectomy. EPILOG Investigators. Evaluation of PTCA to Improve Long-term Outcome by c7E3 GP IIb/IIIa Receptor BlockadeS Ghaffari, D J Kereiakes, A M Lincoff, et al.
The Journal of Clinical Endocrinology and Metabolism|January 11, 2024
Depressive Syndromes in Men With Hypogonadism in the TRAVERSE Trial: Response to Testosterone-Replacement TherapyShalender Bhasin, Stuart Seidman, Thomas G Travison, et al.
Circulation|December 22, 1998
Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart diseaseD F Kong, R M Califf, D P Miller, et al.
The American Journal of Cardiology|May 3, 2011
Comparison of outcomes of unprotected left main versus multivessel coronary artery interventionsShikhar Agarwal, Tarique Zaman, E Murat Tuzcu, et al.
Clinical Cardiology|July 30, 2024
Impact of the COVID-19 Pandemic on Conduct and Results of CLEAR Outcomes TrialAbhayjit Singh, Luke J Laffin, Ashish Sarraju, et al.
Circulation|January 11, 2000
Economic assessment of platelet glycoprotein IIb/IIIa receptor blockade with abciximab and low-dose heparin during percutaneous coronary revascularization: results from the EPILOG randomized trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockadeA M Lincoff, D B Mark, J E Tcheng, et al.
Journal of Cardiovascular Pharmacology|December 23, 2004
Celecoxib, a selective cyclooxygenase-2 inhibitor, decreases monocyte chemoattractant protein-1 expression and neointimal hyperplasia in the rabbit atherosclerotic balloon injury modelKai Wang, Khaldoun Tarakji, Zhongmin Zhou, et al.
Journal of the American College of Cardiology|June 1, 1995
Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT)R A Harrington, A M Lincoff, R M Califf, et al.
American Heart Journal|August 9, 2005
The relationship between baseline risk and mortality in ST-elevation acute myocardial infarction treated with pharmacological reperfusion: insights from the Global Utilization of Strategies To open Occluded arteries (GUSTO) V trialSorin J Brener, A Michael Lincoff, Eric R Bates, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|June 5, 2010
Impact of chronic antiplatelet therapy before hospitalization on ischemic and bleeding events in invasively managed patients with acute coronary syndromes: the ACUITY trialGiuseppe Ambrosio, Steven Steinhubl, Paolo Gresele, et al.
Pageof 54